-
Marchés
-
Actions
Sustainable finance2025 Euronext ESG Trends ReportLire la suiteA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesLire la suiteThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETF
The European market place for ETFsEuronext ETF EuropeLire la suiteInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Fonds
-
Obligations
European Defence BondsGroupe BPCE lists the first bondLire la suiteFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Produits Structurés
-
Dérivés
Where European Government Bonds Meet the FutureFixed Income derivativesLire la suiteTrade mini bond futures on main European government bonds
-
Marchandises
- Vue d'ensemble
- Vue d'ensemble
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Règlement livraison
- Spécifications et dispositions
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesLire la suiteEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Ressources
Designed to help students navigate the complexities of financial marketsEuronext Trading gameLire la suiteJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
Sartorius Stedim Biotech SA: DECLARATION RELATIVE AU NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL
03 Dec 2025 09:48 CET
Nom de l'emetteur
SARTORIUS STEDIM BIOTECH
|
Sartorius Stedim Biotech SA
Sartorius Stedim Biotech S.A. - 13400 Aubagne, France
DECLARATION RELATIVE AU NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL
Article L 233-8-II du Code de commerce et article 223-6 du règlement général de l’AMF
Dénomination de l’émetteur
SARTORIUS STEDIM BIOTECH SA CS 91051 Z. I. Les Paluds Avenue de Jouques 13400 Aubagne
Fichier PDF dépôt réglementaire Document : DECLARATION RELATIVE AU NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL |
| Langue : | Français |
| Entreprise : | Sartorius Stedim Biotech SA |
| Avenue de Jouques | |
| 13781 Aubagne | |
| France | |
| Téléphone : | +33 44 284 5600 |
| E-mail : | sartorius.presse@sartorius.com |
| Internet : | www.sartorius.com |
| ISIN : | FR0013154002 |
| Ticker Euronext : | DIM |
| Catégorie AMF : | Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital |
| EQS News ID : | 2239624 |
| Fin du communiqué | EQS News-Service |
2239624 03-Déc-2025 CET/CEST
QHPBLYYNOCJKUGRJNUNOLAHT_20251130_SSB_IR_Declaration_voting_rights_fr.pdf
Source
Sartorius Stedim Biotech SA
Fournisseur
EQS Group
Company Name
SARTORIUS STED BIO, SARTORIUS STEDIM BIOTECH
ISIN
FR0013154002, FR0013154002
Symbole
DIM, 4DIM
Marché
Euronext